2021
DOI: 10.1016/j.ijpharm.2021.121191
|View full text |Cite
|
Sign up to set email alerts
|

Development of niosomes for encapsulating captopril-quercetin prodrug to combat hypertension

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
10
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 12 publications
(10 citation statements)
references
References 53 publications
0
10
0
Order By: Relevance
“…Globally, HTN continues to be a major risk factor for cardiovascular disease and mortality ( Reboldi et al, 2022 ). HTN is often called the silent killer because it is asymptomatic in many cases and symptoms are difficult to detect without special apparatus, causing around 9.4 million deaths worldwide ( Kalehoff & Oparil, 2020 ; Sayyad et al, 2021 ).…”
Section: Review Of Literaturementioning
confidence: 99%
See 1 more Smart Citation
“…Globally, HTN continues to be a major risk factor for cardiovascular disease and mortality ( Reboldi et al, 2022 ). HTN is often called the silent killer because it is asymptomatic in many cases and symptoms are difficult to detect without special apparatus, causing around 9.4 million deaths worldwide ( Kalehoff & Oparil, 2020 ; Sayyad et al, 2021 ).…”
Section: Review Of Literaturementioning
confidence: 99%
“…Furthermore, effective management of stroke depends mainly on the public's awareness of its warning signs, which could help in earlier detection and better response rates ( Kalehoff & Oparil, 2020 ; Sayyad et al, 2021 ). As HTN is considered a main modifiable risk factor for stroke, there is still a lack of studies that examine hypertensive patients’ awareness of stroke.…”
Section: Review Of Literaturementioning
confidence: 99%
“…However, at room temperature (25 ± 2 °C), the niosomal formula was found to aggregate, indicating that the fluidity of the bilayer membrane increased at higher temperatures (Kulkarni et al 2021 ). Because the lipophilic part rigidity in the niosomes rises at lower temperatures, the sample held at 4 °C was more stable than that kept at 25 °C (Sayyad et al 2021 ). Another essential stability parameter is the niosomes’ capability to retain the drug in its encapsulated form during the storage period.…”
Section: Resultsmentioning
confidence: 99%
“…To this aim, Q, a nonenzymatic antioxidant, has been used for the first time for a OGB to inactivate the possible free radicals during oxygenation. This nonenzymatic antioxidant is quite stable and multifunctional; therefore, Q not only can scavenge the free radicals like ROS but also can bring other features for OGBs like antibacterial properties (Amer et al, 2021; Sayyad et al, 2021). To investigate the effect of Q on free radicals, it is necessary to evaluate the antioxidant properties of specimens.…”
Section: Resultsmentioning
confidence: 99%